Table 7.
Exitus in COVID-19 positive patients: univariate analysis.
| Patients, n | Exitus (n = 69) |
No Exitus (n = 317) |
p |
|---|---|---|---|
| Biochemistries at admission: | |||
| IL-6, pg/mL | 116.2 ± 95 | 89.7 ± 130.5 | NS |
| LDH, IU/L | 372.8 ± 151 | 337.8 ± 180.5 | NS |
| PCR, mg/dL | 12.4 ± 9.1 | 11.7 ± 23.6 | NS |
| D-dimer, mcg/mL | 2912.3 ± 4434 | 4624.3 ± 23778.6 | NS |
| Ferritin, ng/mL | 1831.5 ± 4337 | 1412.7 ± 1732.3 | 0.02 |
| ALT, IU/L | 152.5 ± 521.06 | 50.8 ± 60.2 | 0.001 |
| White blood cells | 9432.1 ± 4802 | 7985.5 ± 4518 | 0.04 |
| AKI, n | 39 (56.5%) | 80 (25.1%) | 0.0001 |
| AKI stage 1, n | 24 (34.7%) | 50 (15.7%) | |
| AKI stage 2, n | 10 (14.4%) | 16 (5%) | |
| AKI stage 3, n | 5 (7%) | 13 (16.2%) |